Funding
← Back to your selection

GL Ventures

Activity from announced rounds

Activity in this selectionUndisclosed

GL Ventures is the Hillhouse-origin early-stage venture firm identified in LTZ and Clipto issuer announcements.

Recorded funding activity

LTZ develops cancer immunotherapies targeting myeloid biology. Clipto supplies tools for searching video and audio libraries, while Anew combines AI models and experiments for drug discovery. These histories remain distinct from the Hillhouse parent and named funds.

Sources
Rounds participated in
5
Confirmed lead rounds
1
2 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$373M
4 disclosed · full round size, not this investor’s share

By stage

Undisclosed5

By primary sector

AI2
Biotech2
Robotics1

By country

United States3
China2

Rounds

5 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Clipto

Clipto builds AI tools for searching and working with video and audio libraries.

$15MFunding
Participant
MoSense

MoSense builds flexible tactile skin and sensing systems for robots.

Participant
LTZ Therapeutics

LTZ Therapeutics develops cancer immunotherapies that target myeloid biology.

$38MUndisclosed
Role not disclosed
Dify

Helps teams build deploy and operate production-grade AI applications and agentic workflows

$30MPre-Series A
Role not disclosed